Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis
about
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other CancersTargeting caspases in cancer therapeuticsAge-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progressionCaveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cellsPhosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low NeurotoxicityThe zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling.Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosisApoptosis induction by doxazosin and other quinazoline alpha1-adrenoceptor antagonists: a new mechanism for cancer treatment?Therapeutic value of quinazoline-based compounds in prostate cancer.Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists.A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells.Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.The role of alpha-blockers in the management of prostate cancerDiscovery of Fluorescence Polarization Probe for the ELISA-Based Antagonist Screening of α1-Adrenergic ReceptorsGrowth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.Sympathetic modulation of immunity: relevance to disease.Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha inductionAdvances in the design and synthesis of prazosin derivatives over the last ten years.Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.The prince and the pauper. A tale of anticancer targeted agents.Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.Expression of heat shock protein 27 in prostate cancer cell lines according to the extent of malignancy and doxazosin treatment.α-blockade, apoptosis, and prostate shrinkage: how are they related?Insights into cardio-oncology: Polypharmacology of quinazoline-based α1-adrenoceptor antagonists.Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitroEffect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signalingEffect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.BPH gene expression profile associated to prostate gland volume
P2860
Q26740401-7C4DAE19-5E0B-4C9B-86C7-09CE494DA42CQ26821986-9FAD73CE-0DB7-4DAE-9A4F-9EF9111316DBQ27027373-666499EE-4E43-4A47-87F7-5A5A584E8DF3Q28476183-659BD9D3-759F-4999-A94F-4E0B64EC3C67Q28551654-CFC48A0C-6A50-4EAC-BB5F-A6EDA22EC534Q28769152-8751F42F-C39C-4526-A2D9-10D4A75221E8Q33218589-01886AE1-0E87-4040-8DFD-8322980313DBQ33746215-53533A6E-9A3C-4472-9410-C0351159F318Q33746225-24A2C8DB-934D-4D84-BBF5-EFAD44440FBEQ34066067-04B39208-4056-44A8-9D67-635FAAEC353CQ34390813-805E1A55-2F4E-4F02-80C7-BFFB405104C9Q35019287-3867F929-1109-49CC-BF61-084B8B1C23D2Q35496529-0E58C898-4299-4742-8659-DA6CC4872BB3Q35784033-BE90FAE4-4D71-4DC9-BECA-CC4C142ACBECQ36172643-091A59C4-191B-4E4D-8168-6982D895576AQ36390245-6B993CBF-C06E-4584-8397-1736FA354621Q36552147-1C6408C7-9204-43AF-9DF4-E30AC9A9A6B1Q36648945-D4F1E4FC-5580-4B59-977C-0BB972C9E59AQ36827500-99BD7919-BB35-4E13-9E7B-75D14BC8224AQ36854494-82F1D5A1-F56A-4F8D-8CBE-BE743A042801Q37042365-A4C4D1FF-AE67-4ACD-98BE-00C3220CBC8EQ37330766-C442ABBA-867B-4BCA-BF63-B751FC85DD03Q37466606-8A9B2875-C221-4357-A8E2-2373AFA69BDAQ38191941-77F613A4-C0FE-4C3C-B02F-728FF240013FQ38504154-9794E2CB-247F-4B6D-AB61-36ADCCB8A807Q39991418-B5CA25C9-A3D9-4C1B-9FF5-8E01A2F1FEC3Q40329139-A1EBEFF4-BF39-4F27-8FED-C2F5BE8599B5Q41827126-930A704D-8E38-4458-9742-274547111085Q41999403-5B7EABB6-79A3-4A46-9AB5-6BDAD131156BQ42103664-264C4DB8-F461-4990-8206-7C960C420077
P2860
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Suppression of human prostate ...... sin via induction of apoptosis
@ast
Suppression of human prostate ...... sin via induction of apoptosis
@en
Suppression of human prostate ...... sin via induction of apoptosis
@en-gb
Suppression of human prostate ...... sin via induction of apoptosis
@nl
type
label
Suppression of human prostate ...... sin via induction of apoptosis
@ast
Suppression of human prostate ...... sin via induction of apoptosis
@en
Suppression of human prostate ...... sin via induction of apoptosis
@en-gb
Suppression of human prostate ...... sin via induction of apoptosis
@nl
prefLabel
Suppression of human prostate ...... sin via induction of apoptosis
@ast
Suppression of human prostate ...... sin via induction of apoptosis
@en
Suppression of human prostate ...... sin via induction of apoptosis
@en-gb
Suppression of human prostate ...... sin via induction of apoptosis
@nl
P3181
P1433
P1476
Suppression of human prostate ...... sin via induction of apoptosis
@en
P2093
C M Benning
N Kyprianou
P304
P3181
P407
P577
2000-08-15T00:00:00Z